A new AI model called MultiAttenNet is showing breakthrough accuracy in detecting brain tumors from MRI scans. Developed by researchers, the hybrid deep learning framework combines convolutional neural networks with Transformer-based attention mechanisms to identify tumors of varying sizes and shapes.

The model was tested on multiple datasets, including the Brain Tumor Segmentation 2023 dataset for gliomas, and public sets for meningioma and pituitary tumors. Results show 98.4% accuracy, 96.8% sensitivity, and a false positive rate of just 1.3%.

MultiAttenNet uses a semi-supervised learning approach, allowing it to train effectively on limited labeled data. This improves its real-world applicability in clinical settings where annotated scans are scarce.

Experts say this technology could reduce diagnostic workload and improve consistency in neuro-oncology, paving the way for real-time, scalable AI-assisted diagnosis.